Linkedin Twitter Envelope

News

Home
/
/
/
The CA of JA3 WP4 on “Repetitive transcranial magnetic stimulation for treatment-resistant major depression” is now available.

The CA of JA3 WP4 on “Repetitive transcranial magnetic stimulation for treatment-resistant major depression” is now available.

We are pleased to announce that the CA of JA3 WP4 on “Repetitive transcranial magnetic stimulation for treatment-resistant major depression” is available.

The purpose of the assessment is to examine the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) in adult patients with treatment-resistant major depression. The analysis included CE-marked rTMS devices.

Final version of the assessment was published in April 2017.

Below is the documentation provided by the authoring team:

OTCA05_Repetitive transcranial magnetic stimulation for TRD
Assessment draft_external expert comments and answers_1
Project plan OTCA05
Project Plan Draft_external expert comments and answers_1

More news

OUR NETWORK

CAREERS

HELP

eunethta@zinl.nl

CONTACT US

This website was produced under the Third EU Health Programme through a service contract with the European Health and Digital Executive Agency (HaDEA) acting under the mandate from the European Commission. The information and views set out in this website are those of the author(s) and do not necessarily reflect the official opinion of the Commission/Executive Agency. The Commission/Executive Agency do not guarantee the accuracy of the data included in this website. Neither the Commission/Executive Agency nor any person acting on the Commission’s/Executive Agency’s behalf may be held responsible for the use which may be made of the information contained therein.

©2021 EUnetHTA All rights reserved.

This website uses cookies to ensure you get the best experience on our website. By using the website you agree to our Privacy Policy and our Terms of Use.
Accept and Close